Milrinone Half-Life
The elimination half-life of milrinone is approximately 1.7-2 hours in patients with normal renal function, but extends significantly to 10-20 hours in patients with renal impairment. 1, 2
Half-Life by Clinical Context
Normal Renal Function
- Adults with heart failure: 1.7-2 hours 3, 4
- Pediatric patients with septic shock: Median 1.47 hours (range 0.62-10.85 hours) 5
- Preterm infants: Approximately 10 hours 6
Renal Impairment
The half-life increases dramatically with declining renal function, as milrinone is primarily cleared by the kidneys (>90% excreted unchanged in urine):
- Severe renal impairment during CVVH: 20.1 ± 3.3 hours 7
- Moderate renal impairment: The FDA label notes that renal impairment "significantly increases the terminal elimination half-life" 1
Critical Clinical Implications
Time to Steady State
Because milrinone has a relatively long half-life (1-10 hours depending on organ function), it can take 3-30 hours to reach 90% of steady state if no loading dose is used 2. This is why:
- A loading dose of 50 mcg/kg over 10 minutes is standard practice 1
- Without loading, therapeutic effects are significantly delayed
- In pediatric septic shock, loading doses of 75 mcg/kg with infusion rates of 0.75-1.0 mcg/kg/min are recommended for immediate hemodynamic effects 5
Duration of Action After Discontinuation
Due to the long elimination half-life, milrinone should be discontinued at the first sign of arrhythmia or excessive hypotension, as effects will persist for hours after stopping the infusion 2. The drug cannot be rapidly reversed.
Dosing Adjustments Required
Patients with renal impairment require significant dose reductions based on creatinine clearance 1:
| CrCl (mL/min/1.73m²) | Infusion Rate (mcg/kg/min) |
|---|---|
| 50 | 0.43 |
| 40 | 0.38 |
| 30 | 0.33 |
| 20 | 0.28 |
| 10 | 0.23 |
| 5 | 0.20 |
Common Pitfalls
Failing to account for renal function: The half-life can increase 10-fold in severe renal impairment, leading to drug accumulation and toxicity 7
Not using a loading dose: Without loading, it takes multiple half-lives (potentially 15-30 hours in renal impairment) to achieve therapeutic levels 2
Expecting rapid offset: After discontinuation, hemodynamic effects persist for 3-4 half-lives (6-8 hours in normal function, up to 80 hours in severe renal impairment)
Inadequate monitoring during continuous infusion: The FDA label emphasizes using calibrated electronic infusion devices and close monitoring 1